Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Dito
E. Dito
Refractory
Phases of clinical research
Metastatic Pancreatic Adenocarcinoma
Pancreatic cancer
Oncology
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
453 Plasma metabolomic signature of novel signal transduction inhibitors from preclinical identification to clinical validation
2014
A.H. Ko
A.H. Tempero
T.B. Bekaii-Saab
Peter Kuhn
R. Courtin
S. Ziyeh
S. Tahiri
Robin Kate Kelley
E. Dito
Anna Ong
R. Linetskaya
A Talasaz
Alan P. Venook
Wolfgang Michael Korn
Show All
Source
Cite
Save
Citations (0)
A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer.
2011
Journal of Clinical Oncology
Andrew H. Ko
M. A. Tempero
Y Shan
Wu Chou Su
Yu-Lin Lin
E. Dito
Anna Ong
G. Yeh
Li-Tzong Chen
Show All
Source
Cite
Save
Citations (14)
1